A Korea–USA advanced battery platform delivering IRA-compliant, China-independent cell technology and materials — proven at pilot scale, ready for U.S. manufacturing.
China controls approximately 80% of the global Li-ion battery supply chain. Western battery companies that attempted to build domestic capacity from scratch have largely failed — not from lack of capital, but from lack of manufacturing know-how.
NLT's model is different. We leverage Korea's world-class battery ecosystem — advanced materials, proven process know-how, and cell production capacity — as a technology transfer hub feeding U.S. manufacturing. This is the most pragmatic, capital-efficient path to IRA-compliant domestic battery production.
Our Korean subsidiary serves as the central integration point for our partner ecosystem, with a pilot line delivering 250,000–300,000 cells/year before U.S. scale-up.
"Korea holds the second-strongest lithium-ion battery ecosystem in the world — combining advanced materials, world-class equipment, deep process know-how, and proven cell production capacity."
Korea-based pilot line proves cell production at scale before U.S. replication — eliminating the manufacturing risk that has felled every previous U.S. battery startup.
NLT's equity stake provides board control over Korean operations — securing investment against equipment, land, and plant, not unsecured promises.
All materials sourced from Korean partners — zero Chinese supply dependency from Day 1. Fully compliant with IRA Section 45X and DoD non-Chinese sourcing requirements.
Purchase order commitments secured before production scale-up — creating partner alignment and de-risking capital deployment throughout the program.
NLT targets high-growth segments where non-Chinese battery sourcing is a structural requirement — insulating revenue from IRA policy uncertainty while accessing premium margins.
NLT's three operating entities cover the full battery value chain — from next-generation cathode and anode materials to high-energy cell development and scale-up manufacturing.
NLT is seeking strategic investors to participate in the Korea integration and U.S. scale-up phase. Our equity governance structure delivers intervention rights, asset-backed security, and KOSDAQ value appreciation — advantages no alliance-based competitor can match.
Equity investment into Korean KOSDAQ entity securing 40–51% board control. Legal due diligence, IP documentation, MOU execution with all Korean partners. Purchase order pipeline formalized before capital deployment.
CWB Prismatic cell pilot line operational in Korea. NLT engineering team embedded on-site for minimum 6 months. Gate criterion: ≥90% cell pass rate before U.S. scale-up decision.
Mirror proven Korea production line at NLT U.S. facility with Korean technical team support. Secure IRA Section 45X Advanced Manufacturing Tax Credit. FEOC-compliant supply chain from Day 1. IRA rollback contingency plan maintained.
Korean VC second-round funding ($8–$12M) leveraging production milestones. Commercial purchase order deliveries to defense and commercial customers. KOSDAQ IR roadshow to drive valuation uplift.
Unlike alliance-based battery platforms, NLT's equity governance structure provides direct intervention rights at the board level, asset-backed capital security, and the ability to direct sub-partner relationships — the critical advantage that alliance structures cannot replicate when quality or delivery issues arise.
NLT's Korean entity acts as the central node connecting specialized Korean partners into a coordinated, FEOC-compliant supply chain — governed by NLT board authority.
Cathode electrode materials and cell chemistry expertise supporting NLT's high-Ni NCM and NCA product series.
Advanced electrode processing and high-capacity cathode systems — materials benchmarked against Chinese equivalents and documented as technically superior.
Battery equipment, automation, and production line technology supporting pilot-to-production scale-up in Korea and the NLT U.S. facility mirror build-out.
Cell manufacturing capability at Korea facility — supporting CWB Prismatic production ramp and technology validation through the pilot phase.
A123, Northvolt, Proterra, 24M — each failed not from lack of capital, but from premature U.S. scale-up without proven process know-how. NLT's model is designed differently.
Pilot production validated in Korea before any U.S. scale-up decision. The ≥90% cell pass rate gate eliminates the manufacturing risk that destroyed Northvolt despite $15B in funding.
As the largest KOSDAQ shareholder (40–51%), NLT can intervene directly at the governance level — unlike alliance models that have no recourse when partners underperform.
DoD and drone/eVTOL customers create revenue independent of IRA policy — structurally hedging against EV incentive rollback that threatens conventional U.S. battery plans.
FEOC-compliant supply chain from Day 1. Korean materials outperform Chinese equivalents in benchmarking — turning compliance into a commercial advantage for DoD customers.
Investment secured by Korean entity's equipment, land, and plant — not unsecured promises. KOSDAQ listing provides additional valuation and liquidity pathway for investors.
NLT operates across materials (cathode, anode), cell development, and scale-up manufacturing — with engineering presence in the USA, Korea, Japan, and China.
Whether you are a defense procurement office, commercial OEM, or strategic investor, NLT welcomes conversations about supply agreements, investment participation, and technology partnerships.
Send a MessageNew Leading Tech Inc
Ann Arbor, Michigan, USA
NLT-Jeonji & NLT-Sojae
South Korea
09:00 AM – 06:00 PM (KST / EST)
Defense & Government Procurement
Commercial OEM Supply
Investor Relations